Similar Posts
CERTIFIED METHADONE ADVOCATE (CMA)-1
ByAdminAdmin 02/22/2023The Advocacy Training Session The training for certification includes a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs. Addiction and Methadone The biological constructs of addiction will be explained in a way that can be understood by lay people (i.e. opiate receptors,…
The NAMA Store
ByAdminAdmin 01/01/2022Book of the Month Didn’t Find a Book? Search Amazon.Com’s Catalog 2.5-Million Titles Enter Keyword Or Browse by Subject And Press Go. NAMA is a proud affiliate of Amazon.Com Your purchase helps NAMA! A Classic and the book that started it…… Federal Regulation of Methadone Treatment by Richard A. Rettig and Adam…
Publication Index-1
ByAdminAdmin 09/22/2021Changes in Methadone Treatment Practices: Results From a National Panel Study, 1988-2000 by Thomas D’Aunno, PhD; Harold A. Pollack, PhD Journal of the American Medical Association Vol. 288, No. 7 August 21, 2002 Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use…
Category: AATOD
ByAdminAdmin 12/26/2021Congratulations to Sara Gefvert, the 2022 Lane/Holden Award Winner! November 2, 2022 The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient…
Related Resources on the Web
ByAdminAdmin 01/31/2022PLEASE NOTE: The inclusion of the following links does not imply the endorsement by NAMA of any information or political perspective contained therein, nor is any guarantee made about the accuracy of such material. Some of the information provided is contrary to the neuropharmacological perspective upon which methadone maintenance treatment is based. Some is…
Comments by Andrew Byrne …Office-Based Treatment of Opiate Addiction with a Sublingual-Tabl eFormulation of Buprenorphine and Naloxon
ByAdminAdmin 08/18/2021Dr Andrew Byrne, Medical Practitioner, Drug and Alcohol New South Wales, Australia Email – [email protected] September 23, 2003 This study randomised consenting heroin dependent subjects to receive one month’s treatment with (i) buprenorphine, (ii) buprenorphine/naloxone or (iii) placebo. For a further 11 months, surviving (sic) patients were followed in an open-label manner for primary outcome…